BCHE and early-onset autosomal dominant Alzheimer disease: The dual inhibition of acetylcholinesterase and butyrylcholinesterase by various plant extracts and their components may be considered a potential therapeutic advantage for neurodegenerative disease to benefit in cognition, global function, and behavioral symptoms, especially in advanced Alzheimer’s disease patients.